Nabta Health has closed a USD 2 million Pre-Series A round, bringing total funding to USD 4.5 million as the company looks to scale its AI-powered women’s health platform across the Middle East and Africa.
Founded in 2017 by Sophie Smith, Nabta operates a hybrid model combining digital care, at-home diagnostics and clinical services. The new capital will be used to expand regional footprint, build new testing and diagnostic pathways, and strengthen clinical infrastructure through hospital partnerships.
The company has gained increasing visibility over the past year. It was named to TIME Magazine’s Top HealthTech Companies 2025 list and recently launched a Women’s Health Centre of Excellence in collaboration with Clemenceau Medical Center Hospital Dubai. Nabta has also expanded its corporate health solutions, targeting employers and insurers looking to address productivity and wellness gaps related to women’s health.
“With this investment, we are aiming to accelerate access to women-centred healthcare that is affordable, mobile-first and designed with cultural context in mind,” said founder and CEO Sophie Smith. She added that demand from employers and insurers is growing as women’s health moves from a moral priority to a recognised business imperative.
Chair Iain McMillan said the new funding marks an inflection point for the company following strong 2025 adoption. He expects further acceleration as Nabta moves toward scale in 2026.
